Induction of Early Growth Response-1 Gene Expression by Calmodulin Antagonist Trifluoperazine through the Activation of Elk-1 in Human Fibrosarcoma HT1080 Cells*
- Soon Young Shin‡,§,
- Seong-Yong Kim‡,
- Jung-Hye Kim‡,
- Do Sik Min¶,
- Jesang Ko‖,
- Ung-Gu Kang**,
- Yong Sik Kim**,
- Taeg Kyu Kwon‡,
- Mi Young Han§,
- Young Ho Kim§§ and
- Young Han Leeদ
- From the ‡Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 705–717, the ¶Department of Physiology, College of Medicine, The Catholic University of Korea, Seoul 137-701, the ‖Immunomodulation Research Center, University of Ulsan, Ulsan 138–736, the **Department of Psychiatry, College of Medicine, Seoul National University, Seoul 151–742, the ‡Department of Immunology, School of Medicine, Keimyung University, Daegu 700–712, the §Cell Biology Laboratory, Korea Research Institute of Bioscience and Biotechnology, P. O. Box 115, Yusung, Taejon 305–600, and the §§Department of Microbiology, Kyungpook National University, Daegu 702–701, South Korea
Abstract
The early growth response gene-1 (Egr-1) is a transcription factor that plays an important role in cell growth and differentiation. It has been known that Egr-1 expression is down-regulated in many types of tumor tissues, including human fibrosarcoma HT1080 cells, and introduction of the Egr-1gene into HT1080 cells inhibits cell growth and tumorigenic potential. Trifluoperazine (TFP), a phenothiazine class calmodulin antagonist, is known to inhibit DNA synthesis and cell proliferation and potentially important in antitumor activities. To understand the regulatory mechanism of Egr-1, we investigated the effect of TFP on expression of Egr-1 in HT1080 cells. Herein, we report thatEgr-1 expression was increased by TFP in synergy with serum at the transcriptional level. Both the Ca2+/calmodulin-dependent protein kinase II inhibitor KN62 and the calcineurin inhibitor cyclosporin A enhanced TFP-dependent increase of Egr-1, suggesting that the Ca2+/calmodulindependent pathway plays a role in regulation of Egr-1 expression in HT1080 cells. The TFP-stimulated increase of the Egr-1 protein was preferentially inhibited by the MEK-specific inhibitor PD98059. In addition, activation of human Egr-1 promoter and the transcriptional activation of the ternary complex factor Elk-1 induced by TFP were inhibited both by pretreatment of PD98059 and by expression of the dominant-negative RasN17. These results indicate that the Ras/MEK/Erk/Elk-1 pathway is necessary for TFP-inducedEgr-1 expression. We propose that the calmodulin antagonist TFP stimulates Egr-1 gene expression by modulating Ras/MEK/Erk and activation of the Elk-1 pathway in human fibrosarcoma HT1080 cells.
- CaMK
- calmodulin-dependent protein kinase
- TFP
- trifluoperazine
- TCF
- ternary complex factor
- DMEM
- Dulbecco's modified Eagle's medium
- MOPS
- 4-morpholinepropanesulfonic acid
- kb
- kilobase(s)
- GAPDH
- glyceraldehyde-3-phosphate dehydrogenase
- PCR
- polymerase chain reaction
- CMV
- cytomegalovirus
- PMA
- phorbol 12-myristate 13-acetate
- CPZ
- chlorpromazine
- SRE
- serum response element
- PKC
- protein kinase C
- MAPK
- mitogen-activated protein kinase
- ERK
- extracellular signal-regulated kinase
- MEK
- MAPK/ERK kinase
- JNK
- c-Jun N-terminal kinase
- KSR
- kinase suppressor of Ras
- Received October 17, 2000.
- Revision received December 19, 2000.
- The American Society for Biochemistry and Molecular Biology, Inc.











